z-logo
open-access-imgOpen Access
Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?
Author(s) -
Blayne Welk,
Jennifer Reid,
Michael Ordon,
Jeffrey Campbell,
Stephanie N. Dixon
Publication year - 2021
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.7135
Subject(s) - gross hematuria , 5 alpha reductase inhibitor , urology , medicine , alpha (finance) , prostatectomy , open prostatectomy , tamsulosin , finasteride , surgery , prostate cancer , prostate , cancer , construct validity , patient satisfaction , hyperplasia
NA

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom